The Pharmacist

SEPTEMBER 12, 2023

Community pharmacists have been urged to share their views on what a pharmacogenetic service should look like in the UK. Clinical academics in Manchester have launched a new survey seeking healthcare professional’s preferences for the development of a future pharmacogenetic service, as part of an NHS trial. And they have stressed that the involvement of […] The post Pharmacists ‘critical to success’ of future pharmacogenetic service appeared first on The Pharmacist.

Community Pharmacies 98

Community Pharmacies 98

STAT

SEPTEMBER 14, 2023

Long Covid goes by  many names. Today, it is no longer a new public health enigma, but the outlook for sufferers is no better than when the condition was first recognized in early 2020. Although its prevalence has recently decreased to 6% of the U.S. adult population, there has been no significant progress in understanding its causes, prevention, or treatment.

364

364

PharmaVoice

SEPTEMBER 11, 2023

After dropping its neuroscience program earlier this year, the clinical-stage oncology company is doubling down on a candidate targeting the MAPK pathway.

Immunity 246

Immunity Immunization 246

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. The participants were: Dr Tim Sandle, Head of GxP Compliance at Bio Products Laboratory Limited (BPL) as moderator; Dr Edward Tidswell, Executive Director within the Microbiological Quality and Sterility Assurance organisation of Merck & Co; Frederic Ayers, Research Scienti

Documentation 125

Documentation 125

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Pharmacist

SEPTEMBER 14, 2023

Community pharmacies in Scotland will be able to participate in a national naloxone emergency supply service from the end of next month. The Royal Pharmaceutical Society (RPS) in Scotland described the move as a ‘huge step forwards’ in making naloxone, which is used to reverse the effects of an opioid overdose, available in all clinical […] The post Scotland introduces national naloxone emergency supply appeared first on The Pharmacist.

Community Pharmacies 128

Community Pharmacies 128

STAT

SEPTEMBER 12, 2023

A panel of advisers to the Centers for Disease Control and Prevention voted 13-1 Tuesday to recommend updated Covid-19 booster shots for all Americans 6 months and older. CDC Director Mandy Cohen signed off on the recommendation hours later, and vaccines would be available within 48 hours. The recommendation applies to mRNA shots from Pfizer-BioNTech and Moderna, both of which were approved by the Food and Drug Administration Monday.

Vaccines 363

Vaccines 363

Pharmafile

SEPTEMBER 15, 2023

GSK and Save the Children have announced that they will be renewing their partnership for an additional five years. GSK plans to invest £15m in the partnership, with the two companies working together to increase rates of childhood vaccination. The partnership aims to reduce the number of ‘zero dose’ children in Ethiopia and Nigeria, meaning […] The post GSK and Save the Children extend partnership for unvaccinated children appeared first on Pharmafile.

Vaccines 118

Vaccines 118

The Pharmacist

SEPTEMBER 15, 2023

Health minister Neil O’Brien has agreed to meet with community pharmacy stakeholders following a debate in parliament which centred on the significant challenges across the sector. The debate held yesterday was called by Conservative MP for Waveney Peter Aldous to highlight the role that community pharmacies play and to address the ‘enormous pressures’ they currently […] The post Health minister agrees to meet with pharmacy stakeholders appeared first on The Pharmacist.

Community Pharmacies 122

Community Pharmacies 122

STAT

SEPTEMBER 12, 2023

The blazing success of weight loss drugs like Wegovy and Mounjaro has electrified the pursuit of new treatments for obesity. For now, Novo Nordisk and Eli Lilly are leading the market with injectable drugs that target receptors of the GLP-1 hormone to mimic the hormone’s effects of helping people feel full. But dozens of companies are also jumping into the race, seeing the potential to make millions of dollars if they can bring to market medications that are oral, longer-lasting, avoid si

Drug Development 363

Drug Development 363

European Pharmaceutical Review

SEPTEMBER 15, 2023

The CBL-0201DD Phase II study evaluating the first-in-class small-molecule drug CBL-514 for Dercum’s disease, a rare disorder, has demonstrated significant efficacy in reducing lipoma size and complete clearance. Dercum’s disease is characterised by painful lipomas developing primarily on the trunk in the body. Currently there are no approved or effective medicine, so the data from the Phase II study shows potential of a treatment for this indication.

Compounding 118

Compounding 118

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

SEPTEMBER 11, 2023

The HER3-targeting treatment could become the next antibody-drug conjugate to emerge from Daiichi Sankyo’s laboratories, after the AstraZeneca-partnered Enhertu.

122

122

The Pharmacist

SEPTEMBER 13, 2023

Pharmacists and pharmacy teams working in general practice and primary care networks (PCNs) have been shortlisted for Cogora’s General Practice Awards 2023. Six pharmacists or pharmacy teams were shortlisted for the pharmacist / pharmacy team of the year category. And multidisciplinary teams were recognised for vaccination services and initiatives to achieve clinical improvement in mental […] The post Pharmacists shortlisted for general practice awards appeared first on The Pharmacist.

Vaccines 116

Vaccines 116

STAT

SEPTEMBER 11, 2023

The Food and Drug Administration announced Monday that it had greenlit two   updated Covid-19 booster shots in people as young as 6 months old, triggering a process that could see the Moderna and Pfizer-BioNTech vaccines become available in doctors’ offices, clinics, and pharmacies later this week. The updated approvals relate only to the two messenger RNA vaccines on the U.S. market.

Vaccines 363

Vaccines 363

Express Pharma

SEPTEMBER 12, 2023

JB Chemicals & Pharmaceuticals recently published its 2 nd Sustainability (ESG) Report. The report informs that the overall Green House Gases (GHG) intensity (i.e. Scope 1 and Scope 2) has been reduced by 19 per cent as compared to last year. A statement from the company informs, “This financial year also witnessed the completion of calculating scope 3 emissions for the first time for JB Pharma, where focus will be on total emissions across the organisation and the external supply chain.

115

115

BioPharma Dive

SEPTEMBER 11, 2023

Pfizer and Moderna, which have seen slowing demand for their coronavirus vaccines, expect to make the reformulated shots available in the U.S. in the coming days.

Vaccines 122

Vaccines 122

The Pharmacist

SEPTEMBER 11, 2023

The National Pharmacy Association (NPA) and independent pharmacy owners have invested a total of £1.2m into a pharmacy app which is designed to lessen operational burdens for independent community pharmacies. The cash injection into Charac, which allows pharmacists to manage repeat prescriptions, access patient records, create bookings and conduct consultations, aims to help ‘enhance’ the […] The post NPA puts cash injection into pharmacy app Charac appeared first on The Pharmacist.

Independent Pharmacies 115

Independent Pharmacies Community Pharmacies 115

STAT

SEPTEMBER 10, 2023

Among people who are still paying attention to Covid-19 , there’s been a recent surge — not just in viral activity but in the concern once again being paid to Covid. Headlines announce that transmission is surging and hospitalizations for Covid are rising by alarming percentages. There’s debate in some places about whether or not to resume wearing masks.

Hospitals 364

Hospitals 364

Pharma Times

SEPTEMBER 15, 2023

The site will contribute to the development and commercialisation of antibody drugs - News - PharmaTimes

140

140

BioPharma Dive

SEPTEMBER 12, 2023

Arialys Therapeutics launched Tuesday with $58 million in funding from a group of life sciences investors that includes Johnson & Johnson’s venture arm.

Immunity 117

Immunity Immunization 117

The Pharmacist

SEPTEMBER 14, 2023

Nicotine vaping is the most effective among widely available smoking cessation aids, researchers have declared. Cytisine and varenicline are also among the most effective tools to help people stop smoking, although these are not widely available, say researchers. Combination nicotine replacement therapies (NRT) – for example combining a patch with gum – were almost nearly […] The post Nicotine vaping is most effective smoking cessation aid, say researchers appeared first on The Pharmacist.

112

112

STAT

SEPTEMBER 12, 2023

WASHINGTON — The leading decongestant used by millions of Americans looking for relief from a stuffy nose is no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient. Advisers to the Food and Drug Administration voted unanimously on Tuesday against the effectiveness of the key drug found in popular versions of Sudafed, Allegra, Dayquil and other medications stocked on store shelves.

362

362

Drug Patent Watch

SEPTEMBER 12, 2023

In the world of patents, the right to exclude others from using or selling an invention is granted only during the patent’s validity. Once a patent expires, this exclusivity vanishes.… The post Understanding Patent Term Extensions: An Overview appeared first on DrugPatentWatch - Make Better Decisions.

111

111

Express Pharma

SEPTEMBER 12, 2023

While there are no marketed drugs for nonalcoholic steatohepatitis (NASH) in the EU or US, most NASH therapies in development primarily focus on treating patients with F2 (moderate fibrosis) or F3 (advanced fibrosis). Of the 33 late-stage pipeline assets in development for NASH, only three focus on decompensated cirrhosis (DC) due to NASH. A further look into the mechanisms of action (MOAs) of each agent reveals that Promethera Biosciences and Cellaion’s HepaStem (heterologous human adult liver

Diabetes 109

Diabetes Immunity Immunization 109

The Pharmacist

SEPTEMBER 14, 2023

Community pharmacy should be included in any local planning meetings around vaccinations in future pandemics, the National Pharmacy Association (NPA) told the Covid public inquiry this week. The sector must be included from the outset in any discussions including supply and resourcing of a vaccination service, the community pharmacy body said in the latest public […] The post Include pharmacy in future pandemic vaccination planning, urges NPA appeared first on The Pharmacist.

Vaccines 112

Vaccines Community Pharmacies 112

STAT

SEPTEMBER 12, 2023

WASHINGTON — There’s a panel of 20 nutrition experts that has outsized influence on the American diet — and the food industry has worked hard to get friendly researchers into the group, new documents obtained by STAT show. The National Potato Council, for example, nominated one of the researchers behind an industry-funded study showing eating french fries each day doesn’t result in more weight gain than eating a comparable amount of almonds.

Documentation 360

Documentation 360

Drug Patent Watch

SEPTEMBER 12, 2023

In a recent STAT article Sanofi CEO Paul Hudson discusses the potential of artificial intelligence (AI) in the pharmaceutical industry. While some in the industry have been hesitant to embrace… The post From Expert AI to Snackable AI: A New Era in Pharma, as Seen by Sanofi’s CEO appeared first on DrugPatentWatch - Make Better Decisions.

109

109

Pharma Times

SEPTEMBER 11, 2023

Both companies will work to advance the development of novel radiopharmaceuticals - News - PharmaTimes

138

138

The Pharmacist

SEPTEMBER 13, 2023

YouTube has committed to expanding the categories of healthcare professionals that it verifies as a reputable source amid concerns pharmacists are currently excluded. This month the online video platform launched new content features which aim to help highlight health videos from trusted channels, including using a badge on videos from registered health creators.

111

111

STAT

SEPTEMBER 15, 2023

The latest goal for the end of polio transmission will almost certainly not be met, according to a frank and concerning report about the future of the decades-long polio eradication effort that was released this week. After having missed multiple deadlines for ending polio transmission, the Global Polio Eradication Initiative had set 2023 as the year when both wild polio viruses would finally be snuffed out and so-called vaccine-derived viruses would also be stopped, putting an end to a family o

Vaccines 355

Vaccines 355

FDA Law Blog: Biosimilars

SEPTEMBER 10, 2023

By Mark A. Tobolowsky — CDER, CBER, and the Oncology Center of Excellence recently published a final guidance document titled “ Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products ” as another part of its real-world evidence (“RWE”) Program. This finalized a draft guidance issued in December 2021, largely similar in substance.

Documentation 108

Documentation Vaccines Drug Development 108

Pharma Times

SEPTEMBER 14, 2023

The report highlights steps needed to ensure future pandemics are handled effectively - News - PharmaTimes

134

134

The Pharmacist

SEPTEMBER 11, 2023

The government is set to review guidelines around the supply and prescribing of medicines as part of its new suicide prevention strategy for England, released today. The Medicines and Healthcare Regulatory Agency (MHRA) is to monitor whether retailers are complying with guidance around the sale of analgesics such as paracetamol, including promotions that exceed the […] The post Government to review medicine guidelines in new suicide prevention strategy appeared first on The Pharmacist.

109

109

STAT

SEPTEMBER 14, 2023

For 40 years, researchers have unsuccessfully tried to explain — or debunk — the “Hispanic Paradox,” the finding that Hispanic Americans live several years longer than white Americans on average, despite having far less income and health care and higher rates of diabetes and obesity. Now, armed with more comprehensive data, powerful genomic tools, and a rich cultural awareness of the communities they study, a new generation of scientists is finally making headway.

Diabetes 353

Diabetes 353

Med Ed 101

SEPTEMBER 13, 2023

One of the most common medication review requests I get from clinical staff in long term care and assisted living facilities is identifying medications that may be contributing to falls. Identifying low blood pressure as a potential contributing factor is usually pretty obvious. It is also obvious to reduce antihypertensive medications (ACEs, ARBs, Diuretics, Calcium […] The post Medications That Cause Low Blood Pressure (Non-Antihypertensives) appeared first on Med Ed 101.

Assisted Living 105

Assisted Living 105

Pharma Times

SEPTEMBER 15, 2023

The method could also be beneficial for Parkinson’s disease and strokes - News - PharmaTimes

136

136